Karen Sims sold $64k of ABUS
Chief Medical Officer at Arbutus Biopharma Corp. 19,348 shares at an average of $3.28, traded Feb 4, 2025, filed Feb 5, 2025.
Score components
- +15RoleOfficer
- +8Trade size$64k at market
- +5Share of holdings soldSold 15% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001447028-25-000039, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 4, 2025 | SOpen-market sale Common Shares10b5-1 | -19,348 | $3.28 | $64k | 106,194 | Feb 5, 2025 |
Related signals
Other insiders at Arbutus Biopharma Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | Arbutus Biopharma Corp | J. Christopher Naftzger General Counsel and CCO | $37k 11,333 shares | -12% | |
| 29Weak | Arbutus Biopharma Corp | Michael J. McElhaugh Interim President & CEO | $78k 23,790 shares | -2% | |
| 30Weak | Arbutus Biopharma Corp | David C Hastings Chief Financial Officer | $73k 22,183 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.